Ibogaine Is Being Sold as a Reset Button. Its Own Researchers Say the Evidence Is 'Modest.'

Amber Capone’s nonprofit, Veterans Exploring Treatment Solutions, says it has funded or supported ibogaine treatment for more than 1,300 veterans. A single treatment can cost upward of $5,000, for a drug the DEA has kept in Schedule I since 1967, which makes it illegal to possess or prescribe in the United States. People are paying that price anyway, and that tells you how badly the existing options have failed them.

Ibogaine may turn out to be medicine. Right now it is a rumor with a price tag.

The rumor got a federal tailwind on April 18, when the president signed an executive order directing the FDA to speed psychedelic reviews. Law firm Frier Levitt’s reading of the order says it points the FDA and DEA toward a Right to Try pathway that names ibogaine, and warns about the drug’s cardiac risk. CNN reports the order includes $50 million for state research, that the FDA accepted an investigational application for an ibogaine derivative built to keep the benefit without the hallucinations or the heart toxicity, and that rescheduling would follow approval, not precede it. Until then, no pharmacist, doctor, or clinic in your state can legally hand it to you.

The heart risk is the part to take seriously. Ibogaine can throw off the electrical timing of the heartbeat, a problem doctors call abnormal rhythm. CNN’s reporting notes several deaths have been associated with it, though the cause is not always clear. The researchers are not hiding from this. Radboud University’s Arnt Schellekens told CNN the evidence remains “modest,” that “we are just not there yet,” and that the drug is “sort of romanticized.” Stanford’s Kirsten Cherian, who led a landmark ibogaine study, called the order a “great step.” Both can be right: the science is worth funding and the sales pitch is ahead of the science.

Think about who hears that pitch. If you have tried to quit and failed, and you are sick, a one-week story where the craving gets switched off is the most seductive sentence in the language. Wanting that is not gullible. It is what hope looks like after the fourth attempt.

Providers can meet it halfway this week. Ask every patient, without a flinch, whether they have looked into ibogaine or plan to travel for it. Write the answer in the chart. If they are going, push for a heart tracing (an ECG) beforehand, a named clinician they can call when they return, and a plan to restart their medication rather than white-knuckle it.

If you are on buprenorphine or methadone, those medicines remain legal, covered by most insurance, and backed by decades of evidence; talk to your prescriber about your heart before changing anything, and keep naloxone within reach. FindTreatment.gov will show you who is nearby.

Hope is not the problem here. Hope without a heart monitor is.